{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:45:17Z","timestamp":1787244317511,"version":"build-2736575974"},"reference-count":39,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"DOI":"10.3201\/eid1807.101371","type":"journal-article","created":{"date-parts":[[2012,6,13]],"date-time":"2012-06-13T15:18:00Z","timestamp":1339600680000},"page":"1072-1080","source":"Crossref","is-referenced-by-count":81,"title":["Predicting Risk for Death from MRSA Bacteremia1"],"prefix":"10.3201","volume":"18","author":[{"given":"Mina","family":"Pastagia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence C.","family":"Kleinman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliesel G.","family":"Lacerda de la Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen G.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","published-online":{"date-parts":[[2012,7]]},"reference":[{"key":"key-10.3201\/eid1807.101371-201206130400-R1","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nrmicro2200","article-title":"Waves of resistance: Staphylococcus aureus in the antibiotic era.","volume":"7","author":"Chambers","year":"2009","journal-title":"Nat Rev Microbiol"},{"key":"key-10.3201\/eid1807.101371-201206130400-R2","doi-asserted-by":"publisher","first-page":"943","DOI":"10.3201\/eid1506.081312","article-title":"Vancomycin-resistant Staphylococcus aureus, Michigan, USA, 2007.","volume":"15","author":"Finks","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid1807.101371-201206130400-R3","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1093\/jac\/dkm437","article-title":"Outcomes with daptomycin versus standard therapy for osteoarticular infections associated with Staphylococcus aureus bacteraemia.","volume":"61","author":"Lalani","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid1807.101371-201206130400-R4","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1378\/chest.08-0011","article-title":"Early microbiological response to linezolid vs vancomycin in ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus.","volume":"134","author":"Wunderink","year":"2008","journal-title":"Chest"},{"key":"key-10.3201\/eid1807.101371-201206130400-R5","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0140-6736(01)05410-1","article-title":"Linezolid resistance in a clinical isolate of Staphylococcus aureus.","volume":"358","author":"Tsiodras","year":"2001","journal-title":"Lancet"},{"key":"key-10.3201\/eid1807.101371-201206130400-R6","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1086\/428616","article-title":"Daptomycin-resistant, methicillin-resistant Staphylococcus aureus bacteremia.","volume":"40","author":"Mangili","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid1807.101371-201206130400-R7","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1093\/jac\/dkm258","article-title":"Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001\u201305.","volume":"60","author":"Steinkraus","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid1807.101371-201206130400-R8","doi-asserted-by":"publisher","first-page":"3883","DOI":"10.1128\/JCM.01388-06","article-title":"Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period.","volume":"44","author":"Wang","year":"2006","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid1807.101371-201206130400-R9","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. CLSI approved standard M100\u2013S16. Wayne (PA): The Institute; 2006."},{"key":"key-10.3201\/eid1807.101371-201206130400-R10","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1128\/JCM.42.6.2398-2402.2004","article-title":"Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia.","volume":"42","author":"Sakoulas","year":"2004","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid1807.101371-201206130400-R11","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1001\/archinte.166.19.2138","article-title":"High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity.","volume":"166","author":"Hidayat","year":"2006","journal-title":"Arch Intern Med"},{"key":"key-10.3201\/eid1807.101371-201206130400-R12","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1086\/524667","article-title":"Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia.","volume":"46","author":"Soriano","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid1807.101371-201206130400-R13","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.1128\/AAC.00113-08","article-title":"Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin.","volume":"52","author":"Lodise","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid1807.101371-201206130400-R14","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1086\/381093","article-title":"Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus.","volume":"38","author":"Charles","year":"2004","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid1807.101371-201206130400-R15","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1086\/596629","article-title":"Clinical features of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia versus those of methicillin-resistant S. aureus bacteremia.","volume":"199","author":"Maor","year":"2009","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid1807.101371-201206130400-R16","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1086\/491710","article-title":"Microbiological features of vancomycin in the 21st century: minimum inhibitory concentration creep, bactericidal\/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains.","volume":"42","author":"Jones","year":"2006","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid1807.101371-201206130400-R17","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1093\/jac\/dki017","article-title":"Evaluation of different methods for detecting methicillin (oxacillin) resistance in Staphylococcus aureus.","volume":"55","author":"Velasco","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid1807.101371-201206130400-R18","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1177\/096228029300200202","article-title":"The statistical basis of meta-analysis.","volume":"2","author":"Fleiss","year":"1993","journal-title":"Stat Methods Med Res"},{"key":"key-10.3201\/eid1807.101371-201206130400-R19","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1001\/jama.298.15.1763","article-title":"Invasive methicillin-resistant Staphylococcus aureus infections in the United States.","volume":"298","author":"Klevens","year":"2007","journal-title":"JAMA"},{"key":"key-10.3201\/eid1807.101371-201206130400-R20","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1086\/313753","article-title":"Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis.","volume":"30","author":"Li","year":"2000","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid1807.101371-201206130400-R21","unstructured":"SAS Institute. SAS 9.1 procedure user's manual. Cary (NC): The Institute, Inc; 2004."},{"key":"key-10.3201\/eid1807.101371-201206130400-R22","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/S0895-4356(96)00236-3","article-title":"A simulation study of the number of events per variable in logistic regression analysis.","volume":"49","author":"Peduzzi","year":"1996","journal-title":"J Clin Epidemiol"},{"key":"key-10.3201\/eid1807.101371-201206130400-R23","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/j.1475-6773.2008.00900.x","article-title":"What's the risk? A simple approach for estimating adjusted risk measures from nonlinear models including logistic regression.","volume":"44","author":"Kleinman","year":"2009","journal-title":"Health Serv Res"},{"key":"key-10.3201\/eid1807.101371-201206130400-R24","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1128\/JCM.02135-08","article-title":"Vancomycin MIC plus heteroresistance and outcome of methicillin-resistant Staphylococcus aureus bacteremia: trends over 11 years.","volume":"47","author":"Musta","year":"2009","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid1807.101371-201206130400-R25","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.1128\/AAC.01365-08","article-title":"Prospective comparison of the clinical impact of heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus (hVISA) and vancomycin-susceptible MRSA.","volume":"53","author":"Horne","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid1807.101371-201206130400-R26","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1086\/596511","article-title":"Reduced susceptibility to vancomycin influences pathogenicity in Staphylococcus aureus infection.","volume":"199","author":"Peleg","year":"2009","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid1807.101371-201206130400-R27","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.1128\/JCM.00582-08","article-title":"Characterization of vancomycin-heteroresistant Staphylococcus aureus from the metropolitan area of Detroit, Michigan, over a 22-year period (1986 to 2007).","volume":"46","author":"Rybak","year":"2008","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid1807.101371-201206130400-R28","doi-asserted-by":"publisher","first-page":"3642","DOI":"10.1128\/AAC.00206-09","article-title":"Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) from 14 cities in China.","volume":"53","author":"Sun","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid1807.101371-201206130400-R29","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1086\/346207","article-title":"Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997\u20132001.","volume":"36","author":"Fridkin","year":"2003","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid1807.101371-201206130400-R30","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1093\/jac\/dkm445","article-title":"Microbiological effects of prior vancomycin use in patients with methicillin-resistant Staphylococcus aureus bacteraemia.","volume":"61","author":"Moise","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid1807.101371-201206130400-R31","doi-asserted-by":"publisher","first-page":"9451","DOI":"10.1073\/pnas.0609839104","article-title":"Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing.","volume":"104","author":"Mwangi","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.3201\/eid1807.101371-201206130400-R32","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1093\/jac\/dkq373","article-title":"Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia.","volume":"65","author":"Paul","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"key-10.3201\/eid1807.101371-201206130400-R33","doi-asserted-by":"publisher","first-page":"e11432","DOI":"10.1371\/journal.pone.0011432","article-title":"Empiric antibiotic therapy for Staphylococcus aureus bacteremia may not reduce in-hospital mortality: a retrospective cohort study.","volume":"5","author":"Schweizer","year":"2010","journal-title":"PLoS ONE"},{"key":"key-10.3201\/eid1807.101371-201206130400-R34","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1086\/587673","article-title":"The deadly toll of invasive methicillin-resistant Staphylococcus aureus infection in community hospitals.","volume":"46","author":"Kaye","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid1807.101371-201206130400-R35","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jinf.2009.07.015","article-title":"Mortality of S. aureus bacteremia and infectious diseases specialist consultation\u2014a study of 521 patients in Germany.","volume":"59","author":"Rieg","year":"2009","journal-title":"J Infect"},{"key":"key-10.3201\/eid1807.101371-201206130400-R36","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/MD.0b013e3181b8fccb","article-title":"Infectious diseases consultation lowers mortality from Staphylococcus aureus bacteremia.","volume":"88","author":"Lahey","year":"2009","journal-title":"Medicine (Baltimore)"},{"key":"key-10.3201\/eid1807.101371-201206130400-R37","doi-asserted-by":"publisher","first-page":"3162","DOI":"10.1128\/AAC.00093-09","article-title":"Nine-hospital study comparing broth microdilution and Etest method results for vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus.","volume":"53","author":"Sader","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid1807.101371-201206130400-R38","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1128\/JCM.39.7.2439-2444.2001","article-title":"Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides.","volume":"39","author":"Walsh","year":"2001","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid1807.101371-201206130400-R39","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1128\/JCM.01508-06","article-title":"A multicenter study evaluating the current strategies for isolating Staphylococcus aureus strains with reduced susceptibility to glycopeptides.","volume":"45","author":"Wootton","year":"2007","journal-title":"J Clin Microbiol"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/18\/7\/10-1371_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T23:14:58Z","timestamp":1733267698000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/18\/7\/10-1371_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":39,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2012,7]]}},"URL":"https:\/\/doi.org\/10.3201\/eid1807.101371","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}